<unk> (injection) is a thrombolytic agent that is FDA approved for the treatment of acute myocardial infarction (AMI) in adults for the improvement of ventricular function following AMI, the reduction of the incidence of congestive heart failure, and the reduction of mortality associated with AMI.<unk> is also indicated for the management of acute ischemic stroke in adults for improving neurological recovery and reducing the incidence of disability and the management of acute massive pulmonary embolism (PE) in adults.   Common adverse reactions include hemorrhage.
Alteplase 
Tenecteplase
Argatroban
Pancrelipase
Prasugrel
Reteplase
Bemiparin
Otamixaban